MB

Marc Blondel

CN CNRS: 3 patents #978 of 11,908Top 9%
UP Universite De Poitiers: 2 patents #20 of 163Top 15%
UV Univ Paris Xiii Paris-Nord Villetaneuse: 1 patents #13 of 57Top 25%
UC Université Paris Cité: 1 patents #123 of 608Top 25%
UO Universite De Bretagne Occidentale: 1 patents #30 of 142Top 25%
UP Universite Paris-Saclay: 1 patents #55 of 210Top 30%
U2 Universite Victor Segalen-Bordeaux 2: 1 patents #6 of 36Top 20%
IC Institut Curie: 1 patents #118 of 348Top 35%
📍 Aix-les-Bains, FR: #22 of 150 inventorsTop 15%
Overall (All Time): #1,145,724 of 4,157,543Top 30%
4
Patents All Time

Issued Patents All Time

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
11406631 Hydrazone derivatives for preventing or treating EBV-related cancers Alicia Quillevere, Cécile Voisset, Maria José Lista, Robin Fahraeus, Chrysoula Daskalogianni +5 more 2022-08-09
8252958 Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells Frederic Becq, Deborah Triboullard 2012-08-28
8129402 Screening molecules with anti-prion activity: kits, methods and screened molecules Christophe Cullin, Jean Michel Vierfond, Stéphane Bach, Nicolas Talarek, Yvette Mettey 2012-03-06
7932422 Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases Anne Bertolotti 2011-04-26